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Introduction  
Chronic kidney disease (CKD ) is defined
1
 by KDIGO as abnormalities of 
kidney function or structure, present for more than 3 months, with implications 
for health: 
1. Albuminuria >30mg/ 24 hours   
2. Abnormal urinary sediments 
3. Dyselectrolytemias and other abnormalities due to tubular disorders 
4. Abnormal histology 
5. Abnormal imaging 
6. History of renal transplantation. 
7. Decreased GFR < 60 ml/ min/1.73m
2
 (GFR categories G3a – 5) 
Based on Glomerular filtration rate (GFR), the 5 categories are 
Category  GFR in ml/ min per 1.73 m
2 
G1  > 90 
G2  60 to 89 
G3a  45 to 59  
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G3b  30 to 44 
G4  15 to 29 
G5  less than 15 (End stage renal disease / ESRD ) 
 The incidence and prevalence of chronic kidney disease is steadily increasing 
worldwide. This is largely due to the diabetes epidemic. According to Centre for 
Disease Control (CDC) data, renal problems like nephritis and nephrosis 
constitute the ninth common case of death
2
in United States. And essential 
hypertension and hypertensive renal disease is the thirteenth common cause of 
mortality
2
. In CKD population the major cause of death is by cardiovascular 
event. The risk of cardiovascular death increases with each stage of progression 
of CKD. In India, the projected number of deaths due to CKD in 2008 was 
around 5.21 million and is expected to be around 7.63 million in 2020
3
. 
 Once the patient reaches ESRD, one or the other form of renal replacement 
therapy ( RRT ) becomes mandatory for survival. The available form of RRT 
includes dialysis and renal transplantation. Dialysis can be either Peritoneal 
dialysis or Hemodialysis. Overall, kidney transplantation is considered superior 
to dialysis unless there are contraindications to it and can be said as the best 
form of RRT that can be offered to a patient with ESRD. Dialysis does not 
reverse or improve some complications of uremia such as anemia, sexual 
dysfunction, peripheral and autonomic neuropathy, but a transplanted kidney 
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does. Thus the quality of life of transplant recipients is markedly better than that 
of chronic dialysis patients. There is also a significant decrease in 
cardiovascular mortality in transplant recipients
4
.  
The source of kidney for transplant can be either from live or cadaver donors. 
The outcome is expectedly better in recipients of kidneys from live donors. On 
an average, the living donor kidney functions for 12 to 20 years and that from 
deceased donor kidney functions for 8 to 12 years.  The proportion of 
contribution from either source varies from place to place in the globe. In 
western world, majority of the kidneys are retrieved from cadavers. And live 
donation is steadily increasing there. In countries like Japan live donors form 
the major source of kidneys for transplant.  
In India where 3000 – 4000 renal transplantations take place annually, the donor 
pool is mainly from live donors who are mostly related to the recipient. The 
awareness about deceased donation is increasing steadily in India. In a few 
states viz. Tamilnadu, Gujarat and Maharashtra, deceased donors form a 
significant percentage of renal transplantation. Still cadaver donors contribute 
only for 2 percent of the total renal transplantation. In other words, 98 percent 
of kidneys for transplant is from live donors. 
The live donors are related to the recipient in the form of parents/ siblings/ 
children/ aunt /uncle and in some cases can be just emotionally related. The 
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evaluation of donor is done meticulously and comprehensively to ensure he/she 
is healthy and fit for donation. And moreover the donor is not at increased risk 
of renal disease or other major illnesses in the future. 
After donating a kidney, the remaining kidney increases its function to 
compensate for its lost pair. In a short time after donation, the total GFR of the 
single kidney reaches 70 - 80% of the two kidney GFR. But do donors show 
signs of loss of half of their renal tissue with time, such as development of 
proteinuria, hypertension or accelerated decline in renal function with aging? 
There have been several studies that have been reassuring and some studies 
revealing the risks acquired due to donation. This is yet another study in South 
Indian kidney donor population.  
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AIMS OF THE STUDY 
1. To evaluate kidney donors, after donor nephrectomy, for their current 
precise state of renal function 
2. To look for development of new onset – proteinuria, hypertension, 
anemia or diabetes in the above group 
3. To assess for the frequency of complications that occurred to them in the 
immediate post- operative period 
4. To know about development of any significant medical problems, which 
might be or might not be related to kidney donation 
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Review of literature 
 
HISTORY OF RENAL TRANSPLANTATION 
The first successful live donor renal transplantation in the world was done 
by John Murray in December 23, 1954
5
. It was between identical twin brothers 
at the Peter Bent Brigham Hospital, Massachusetts. The graft functioned for 
eight years. This was the first breakthrough that continues to change the lives of 
millions of CKD patients worldwide. 
Total body irradiation was used to suppress the immunity of the recipient 
to tolerate the graft
6
. Azathioprine was the first immunosuppressant drug to be 
used in 1960
7
. Then came steroids, which was initially used for reversal of 
rejection and later for prevention. Cyclosporine was first used in 1978 and 
Tacrolimus in 1987. Induction agents have been in use since early 1980. 
Sirolimus was introduced in 1999. The last drug to be approved by FDA was 
Belatacept. 
As the science of immune-suppression evolved, successful renal 
transplantation also evolved to donation from fraternal twins to sibling donation 
to non sibling donors. Deceased donor renal transplantation was first 
successfully done in 1962 in Boston.  
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In India, the first successful transplant was done in Christian Medical 
College, Vellore in February, 1961 by Dr KV Johny And Dr.Mohan Rao. More 
than 40 years since then, there are as more than 200 renal transplant centers in 
India. The transplantation of human organs ac, 1994 (THO/ HOTA) regulates 
the transplant programs in India. It prohibits live unrelated transplant and 
legalizes deceased donation after confirmation of brain-death. 
        As of now, renal transplantation has become the definite therapy for 
patients with ESRD. The proportion of live and deceased donors in a population 
is determined by medical, societal and cultural factors.  
DECEASED DONORS 
Kidneys can be harvested from patients who are brain-dead or after cardiac 
death. In Spain, almost 95 percent of organs are retrieved from deceased donors. 
The reason for such a high rate in Spain is its policy that, for all eligible 
cadavers consent is presumed unless they opt out
8
. In United States of America, 
deceased donors contribute 50 percent of the donor pool. Due to increased 
incidence and prevalence of ESRD, the number of patients on waiting list for 
deceased donor kidneys is very high. And there is annual rise in mortality for 
patients who are on waiting list. The chance of getting a deceased kidney goes 
down for highly sensitized patients and for those with high PRA (Panel 
Reactive Antibody). To improve their chances of survival, living donor 
transplantation is the alternate option. 
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LIVE DONORS 
With the presently available immunosuppressive medications, use of 
laparoscopic donor nephrectomy and superior graft function, living donors 
continue to rise. Persons who are medically and psychologically fit can donate 
their kidneys irrespective of the biological relationship to the recipient. 
Live donors can be related or unrelated to the recipient. These donors know who 
the recipient is and they are called as directed - donors. The only benefit of this 
live donation is the level of psychological satisfaction achieved on seeing their 
donated kidney functioning well in the recipient. Non – directed donors are 
those who come forward to donate one of their kidneys to some unknown 
ESRD patients. They are also called as altruistic donors. In United States, non – 
directed donors contribute about 2.5 of living donor transplantation. These non 
– directed donors may not feel the psychological satisfaction perceived by 
directed donors. 
The live donors are usually blood group compatible with their recipients. In 
case there is no blood group compatible donor, there are still two options for 
live donation. First is the use of paired kidney exchange or simply the donor 
swapping. Second, transplant can be safely done from an ABO incompatible 
donor after following specific immunosuppression protocols to remove and 
reduce the anti-blood group antibodies in the recipient. 
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The outcomes of patients who are on maintenance dialysis for longer duration 
before transplant are inferior to those who get an allograft early. This waiting 
time is usually longer for deceased donor transplant. The survival advantage for 
recipients is most likely with a live donor. In some situations, when a live donor 
is readily available, transplant is done even before the commencement of 
dialysis. This is called Pre-Emptive transplantation and is done in children and 
in patients with type 1 Diabetes mellitus. 
The donor evaluation follows the Amsterdam guidelines
9
 adopted by the 
Transplantation society in 2004. Despite the willingness to donate, there are a 
few contraindications to live kidney donation, both, absolute and relative. They 
are: 
ABSOLUTE CONTRAINIDICATIONS TO KIDNEY DONATION 
1. Presence of renal disease  (GFR < 80ml/min, proteinuria > 300 mg/ day) 
2. Significant urological or renal abnormalities 
3. Active malignancy 
4. Presence of transmissible infections like HIV, HBV, HCV 
5. Poorly controlled psychiatric illness or substance abuse 
6. Co- morbid conditions that puts donor at significant risk for surgery 
7. Present pregnancy  
8. Cognitive deficit 
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9. Uncontrolled hypertension or requiring multiple medications 
10. Recurrent renal stones or bilateral renal stones 
11. Diabetes mellitus 
12. History of thrombotic disorders or inherited hypercoagulable conditions 
RELATIVE CONTRAINDICATIONS TO KIDNEY DONATION 
1. Age < 18 or > 65 
2. Mild or borderline hypertension 
3. Mild urinary abnormalities in the absence of a fall in GFR 
4. Obesity 
5. Young donors with risk for future development of diabetes mellitus 
DONOR WORK UP 
The willing donor undergoes comprehensive evaluation before donation. First 
and foremost is the consent of the donor for the whole process. It should be 
made by competent adult, free of coercion and after understanding the risks and 
benefits of donation, all of which is assessed by psychiatric evaluation
10
. The 
donor has the right to withdraw from the evaluation at any time during the 
procedure. The donor should be aware of the alternative treatment options for 
the intended recipient. 
The initial evaluation consists of checking for blood group compatibility and 
preliminary crossmatching for the presence of antibodies against donor cells. 
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Subsequent evaluation follows the universal medical goals to ensure the donor, 
1. Is healthy enough to undergo the surgical procedure 
2. Has normal renal function with minimal risk of future renal disease 
3. Is not at risk of transmission of communicable disease or malignancy to 
the recipient 
4. Is not at increased risk of medical conditions that can affect the residual 
renal function 
The steps include: 
1. Blood grouping and preliminary crossmatching 
2. Urinalysis and urine culture 
3. 24 hour urine collection for protein and creatinine 
4. Calculation of creatinine clearance or nuclear medicine test for GFR 
measurement 
5. Complete blood count, PT and aPTT 
6. Fasting blood sugar and Oral Glucose tolerance test  
7. Viral serologies for HIV, HBV, HCV 
8. Liver function tests 
9. Electrolytes panel 
10. ECG 
11. CXR 
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12. Cardiac screening 
13. USG abdomen 
14. Papanicolau smear for women 
15. CT angiogram of renal vessels 
16. Urine pregnancy test for women in reproductive age group 
17. Mammogram in women > 40 years of age 
18. Serum protein electrophoresis for donors > 60 yearrs 
METHODS OF GFR ESTIMATION 
In case of live donation, estimation of renal function of both the kidneys of the 
donor is vital. Total GFR less than 80 ml/ min is an absolute contraindication to 
donation, though this cut-off is lowered in some centers. There are numerous 
methods for estimation and measurement of GFR. They are: 
1. Creatinine clearance 
 
2. eGFR calculated by one of the following formulae: 
a) Cockcroft Gault formula 
b) aMDRD11 equation (2006) 
c) CKD EPI – creatinine12 equation (2009) 
d) CKD EPI – cystatin equation (2012)13 
e) CKD EPI – creatinine + cystatin (2012)13 
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3. GFR measurement by nuclear isotopes 
Creatinine clearance: 
It is measured by dividing 24- hour urine creatinine excretion by the plasma 
creatinine. i.e , 
Creatinine clearance = U x V / P 
Where, 
 U – urinary creatinine concentration  
V – urine volume 
P – plasma creatinine concentration 
The calculated creatinine clearance is finally adjusted for body surface area 
(BSA) and is given as ml / min / 1.73 m
2 
Creatinine is freely filtered by the glomerulus and neither reabsorbed or 
metabolized by the tubules. But 10 to 40 percent of total urinary creatinine is 
secreted by the tubules. This can rise to 50 percent with decrease in GFR. Thus 
creatinine clearance usually overestimates GFR. This is partially offset by the 
overestimation of plasma creatinine in the denominator by the Modified  Jaffes’ 
method.  
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A small percentage of creatinine is also eliminated by the action of bacterial 
creatininase in the gut, particularly in patients with advanced renal failure. 
Creatinine clearance provides a fair estimation of what the upper limit of GFR 
can be. This is a cost effective of measuring GFR. The major disadvantage is it 
requires collection of urine for 24 hours, which is cumbersome. Since the same 
24 hour urine collection can be useful for quantifying protein excretion, 
creatinine clearance is used for measuring GFR in most donor work up 
protocols. 
eGFR by Cockcroft – Gault (CG) equation: 
when the age, body weight and serum creatinine are known, GFR is estimated 
by, 
eGFR  = ( 140 – Age in years ) x lean body weight    
                 creatinine in mg/ dl x 72 
for females, the calculated value is multiplied by 0.85, due to their smaller 
muscle mass. 
eGFR by CG equation is not adjusted for BSA. It is not accurate when GFR is 
above 60 ml/min. It was originally developed using older creatinine assay 
methods which have been obsolete now. It usually overestimates GFR by 10 to 
40 percent. Still, though valuable in the setting of drug dosing, this is also useful 
in donor eGFR estimation. 
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eGFR by aMDRD equation: 
The original MDRD (Modification of Diet in Renal Disease) or the Levey 
formula used six variables, viz. age, sex, race, creatinine , urea, albumin to 
calculate eGFR which was fairly accurate and standardized to iothalamate 
clearance. 
This was later modified with only four variables, viz. age, sex, race and 
creatinine and called as abbreviated MDRD (aMDRD). This is as good as the 
six variable equation. 
GFR = 186 x Srcr
-1.154 
x Age
-0.203 
x 0.742 (if female) x 1.210 (if black) 
aMDRD is validated in type 1 diabetics, kidney transplant recipients and 
African Americans, unlike MDRD. Like CG equation, it loses its precision in 
higher GFR. This equation was accurate when the GFR is less than 60 ml/ min 
and it loses its accuracy in higher GFR. It is not accepted for eGFR calculation 
when the GFR is more than 60 ml/ min in North America. In United Kingdom, 
it is not an accepted formula to report eGFR more than 90 ml/ min. 
eGFR by CKD EPI creatinine (2009): 
CKD Epidemiological Collaboration study equation is more accurate than 
aMDRD across a wide range of characters like age, sex, muscle mass and race. 
It is also better than aMDRD in persons with normal or slightly reduced GFR. 
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GFR = 141 x minimum (Sr.cr/k,1)
α
 x maximum (Sr.cr/ k,1)
1.209
 x 0.903 Age 
x1.018 (if female) x 1.157 (if black) 
All the above equations estimate GFR with the help of measured creatinine. 
They may not be useful for GFR estimation in the following situations: 
1. For those on vegetarian diet 
2. Those taking creatinine supplements 
3. Unusual muscle mass 
4. Unusual body weight (obese, amputees) 
5. Pregnancy  
Cystatin C is 13 kiloDalton protein produced at a fairly constant rate by all 
nucleated cells. It is freely filtered by the glomerulus and catabolized by the 
tubules, its urinary excretion being negligible. The generation of cystatin C is 
not related to muscle mass or dietary intake. But inflammation, thyroid 
dysfunction and steroid intake can affect the serum levels. Two equations use 
cystatin C to estimate GFR. 
eGFR by CKD –EPI cystatin(2012): 
This equation is not superior to CKD – EPI creatinine equation in terms of 
accuracy. It is valuable in estimating GFR in population with low creatinine 
production, like children, elderly and those with cirrhosis of the liver. 
24 
 
eGFR by CKD – EPI  creatinine-cystatin (2012): 
The equation combining both creatinine and cystatin C is accurate in predicting 
GFR than when either is used alone. 
KDIGO recommends CKD – EPI creatinine 2009 equation be used for 
estimating eGFR in adults with kidney diseases. And to use cystatin C based 
equations where eGFR is between 45 to 59 ml/min with no other markers of 
renal damage.  
GFR measurement by nuclear isotopes: 
With the difficulties in performing Inulin clearance and non – availability in 
most places, GFR measurement by nuclear isotopes are becoming the current 
gold standard of measuring GFR. 
The isotopes used include 
1. 99mTc – DTPA ( Diethylene Triamine Penta Acetic acid) 
2. 51Cr – EDTA (Ethylene Diamine Tetra Acetic acid) 
3. 125I – Iothalamate  
4. 99mTc – MAG3 (Mercapto Acetyl Triglycine) 
5. 99mTc EC (Ethylene di Cysteine) 
6. 99mTc – DMSA (Dimercapto succinic acid) 
7. Iohexol 
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Of these, Tc - DTPA and Tc - EC are used for measuring GFR in normal 
individuals and Tc – MAG3 for those with impaired kidney function. 
The clearances are calculated from multiple plasma estimations or by a gamma 
camera based clearance method. The camera based method is commonly used in 
many centers. 
URINALYSIS: 
Normal daily protein excretion is less than 150 mg. Proteinuria greater than 250 
mg in 24 hours urine collection needs re-evaluation. Persistence of proteinuria 
indicates renal disease and precludes donation. 
Hematuria is defined as the presence of more than 5 RBCs per HPF. Presence of 
hematuria needs systematic evaluation to rule out glomerular diseases, familial 
causes like Thin Basement Membrane Disease, Alports’ Syndrome, renal 
calculi and infections. Cystoscopic examination is done to rule out bladder 
malignancy in elderly donors.  
Pyuria is usually done to urinary tract infections and prostatis. It may also be 
due to nephrolithiasis, tubulointerstitial diseases or rarely genitourinary 
tuberculosis. 
These are excluded before donation. 
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HYPERTENSION: 
JNC 7 defines hypertension as blood pressure greater than 140/ 90 and is staged 
as  
Stage Systolic BP in mm of Hg Diastolic BP in mm of Hg 
Pre- hypertension 120 - 130 80 – 89 
Stage 1 140 – 159 90 – 99 
Stage 2 160 & above 100 & above 
 
Donors with mild hypertension, well controlled with drugs, with normal GFR, 
normal urinalysis and without target organ damage are eligible to donate. As 
already mentioned, uncontrolled hypertension or resistant hypertension 
precludes kidney donation. They should be explained of the little chance of 
progression of hypertension and the need for frequent follow-up. 
 
DIABETES MELLITUS: 
American Diabetes Association defines diabetes mellitus by the presence of one 
of the following
14
: 
1. Fasting plasma glucose (FPG) > 126 mg/ dl on two or more occasions 
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2. 2 hour plasma glucose after 75 gm glucose is > 200 mg/ dl on two or 
more occasions 
3. Random sugar > 200 mg/ dl in the presence of polyuria, polyphagia and 
polydipsia 
4. Glycated Hemoglobin  > 6.5 % 
Impaired Fasting Glucose (IFG)   – FPG between 100 to 125 mg/ dl 
Impaired glucose tolerance (IGT) – 2 hour post between 140 to 199 mg/ dl 
Frank diabetics cannot donate their kidneys. Persons with IFG and IGT are at 
increased risk for future diabetes. Presence of other comorbid conditions 
precludes donation in this group also. Elderly, normotensive, non-obese persons 
with IFG and IGT can be evaluated further for kidney donation. 
OBESITY: 
BMI more than 30 is considered as obesity.  It is considered to be a risk factor 
for metabolic syndrome, diabetes mellitus, hypertension, fatty liver, 
dyslipidemia,  proteinuria, nephrolithiasis, and chronic kidney disease. There 
are many transplant centers across that preclude obese donors with BMI more 
than 35. All obese donors who are otherwise fit for donation should be 
encouraged to lose weight prior to donation. Post donation, it should be stressed 
upon them to continue their weight control methods.  The short term renal 
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function in obese donors post donation is similar to non-obese donors
15
.  The 
surgical complications are also more in this group. 
INFECTIONS: 
Transmissible infections, like HIV, HBV
16
, HCV
17
, CMV, EBV, HHV-6, HHV- 
8, tuberculosis are thoroughly screened in the donor to prevent morbidity and 
secondary renal diseases in the recipient. 
MALIGNANCY: 
History of familial cancer syndromes or previous history of cancer is reviewed 
with the donor, after which age and symptom appropriate screening for cancer 
is done. Potential donors with melanoma, lung cancer, renal cell carcinoma, 
hepatoma and hematological malignancies are excluded from donation.  Donors 
treated for low grade cancer, after a sustained disease-free interval can be 
considered cured and subjected to evaluation for donor nephrectomy
19
. Though 
the risk of transmission of malignancy is reduced but not zero even in this 
group. 
NEPHROLITHIASIS: 
AN ASYMPTOMATIC POTENTIAL DONOR WITH HISTORY OF A SINGLE STONE 
may be suitable for kidney donation if: 
1. No hypercalcuria, hyperuricemia, or metabolic acidosis 
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2. No cystinuria or hyperoxaluria 
3. No urinary tract infection 
4. Multiple stones or nephrocalcinosis are not evident on CT 
AN ASYMPTOMATIC POTENTIAL DONOR WITH A CURRENT SINGLE STONE 
may be suitable if, 
The donor meets the criteria shown previously for single stone 
formers and current stone <1.5 cm, or potentially removable during 
the transplant 
STONE FORMERS WHO SHOULD NOT DONATE are those with, 
1.Nephrocalcinosis on x-ray or bilateral stone disease 
2.Stone types with high recurrence rates and are difficult to prevent 
In one Italian study, 10.3% of donors had developed their first renal 
stone in a span of 8 years post donation
20
. 
CARDIOVASCULAR RISK ASSESSMENT: 
The donors can be classified into three categories for peri-operative mortality 
based on the presence of risk factors. They are: 
 Major  predictors 
1. unstable coronary syndromes 
2. decompensated heart failure 
30 
 
3. significant arrhythmias and  
4. severe valvular disease are contraindications to live kidney donation 
 
Most intermediate predictors 
1. mild angina 
2. previous myocardial infarction 
3. compensated or prior heart failure and  
4. diabetes mellitus are contraindications to donation 
 
Minor predictors 
1.older age, 
2.abnormal ECG 
3.  rhythm other than sinus 
4. low cardiac functional capacity 
5. history of stroke, and 
6. uncontrolled hypertension—warrant individual consideration 
PULMONARY ASSESSMENT: 
Donors need not undergo a routine pulmonary examination unless they are at 
risk  for COPD or restrictive lung disease. Donors who smoke should be 
advised to stop it 4 weeks prior to surgery. Alcohol abstinence for 4 weeks prior 
to surgery is advised to reduce the peri-operative complications. 
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FINAL CROSS MATCH: 
After making sure the donor is fit to donate, final cross matching is done on the 
day of surgery. If the final cross match is negative, transplantation is done. 
DONOR NEPHRECTOMY 
The kidneys can be removed from the donor by either open surgical approach or 
by laparoscopic method. 
Open surgical method is a time – tested procedure. Retroperitoneal approach is 
used. It takes about 2 to 3 hours. The intra – operative complications are 
minimal. 
But it usually leaves a long scar and the donor needs to be in hospital for 5 to 7 
days. Moreover it takes 6 to 8 weeks to resume work. 
Laparoscopic nephrectomy is the procedure of choice wherever there is skill 
and expertise. The scar is minimal and has better cosmetic appeal. The hospital 
stay is also shorter, 1 to 2 days. And donors can resume work after 3 to 4 weeks. 
Due to delay in procedure, 3 to 4 hours, there is prolongation of warm ischemia 
time. Despite this drawback, long tern graft outcomes are similar between the 
two methods. Because of significant benefits to the donor, laparoscopic 
nephrectomy is being increasingly used. In United States, 75 percent of donor 
nephrectomies are done by laparoscopic method. This has clearly led to the 
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increase in live donation there. Some centers use hand assisted laparoscopic 
method for better results. In case of any unexpected bleeding or unseen 
anatomic abnormality, the procedure can very well converted to open method. 
ADAPTATION AFTER DONOR NEPHRECTOMY 
After nephrectomy, the remaining kidney undergoes hyperfiltration and 
hyperperfusion to increase its GFR. In few days to weeks, the GFR reaches 
nearly 70 to 80 % of the pre – donation GFR. This is by increase in single 
nephron GFR. This rise is dependent on the renal reserve of the donor and 
usually decreases with age. The hyperfiltration is also accompanied by increase 
in renal parenchymal volume (RPV). RPV correlated positively with single 
kidney GFR and negatively with age
6
 .It is not known for sure yet whether this 
hyperfiltration can turn maladaptive as in other pathological states like diabetes.  
The GFR increases for an average of 15 to 17 years and remains stable for 
another 8 years. After 23 to 25 years it shows age related decline
21
. There is 
increase in protein excretion due to hyperfiltration
21
. Narkun -Burkess DM et 
al
22
 compared 56 world war II veterans who had undergone unilateral 
nephrectomy following trauma with other veterans who had not. The follow-up 
was done 45 years after nephrrectomy and he found that the former group 
neither had increased mortality nor increased incidence of ESRD. 
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IMMEDIATE RISKS 
The surgical complications occur in 1 to 3 percent of donors and include 
1. Infections of surgical site 
2. Pneumonia 
3. Urinary tract infection 
4. Bleeding  
5. Allergic reactions to anesthesia  
The surgical mortality rate with donor nephrectomy is 1 to 3 per 10,000, 
compared to 0.4 per 10, 000 in the age – matched general population23. This has 
been observed in a study over 20 year period. 
LONG TERM RISKS 
Earlier, donors who were otherwise fully healthy, without any medical 
problems, were only eligible to donate. With relaxation of co- morbid 
conditions, otherwise called as Isolated Medical Abnormalities, that can be 
present in the donor, like mild hypertension, impaired fasting glucose, impaired 
glucose tolerance, obesity and so on, there has to be a close monitoring of renal 
donors after nephrectomy.  There have been several studies in assessing the 
long term outcomes of renal donors over different follow up periods. In a study 
by Goldfarb DA et al
24
, renal donor outcomes 25 years after donation were 
analyzed. He concluded that renal function is well preserved 25 years following 
34 
 
donation. There is increase in protein excretion particularly in males. This was 
seen in those who had borderline proteinuria before donation. There was no 
significant difference in blood pressure or renal function between males and 
females or in different age groups. The incidence of microalbuminuria was 
reported to be 13 %
24
. In a longitudinal study by R Saran et al
25
, donor were 
evaluated twice after donation, with an average of ten years between each. They 
concluded that there is increased prevalence of microalbumiuria and 
hypertension but renal function is well reserved.  The long term risk of ESRD in 
renal donors is 0.3% though low, is ten times that of general population of 
0.04%
4
. There are a few negative studies that caution against live donation . 
Kidney function estimated using Cockcroft Gault Formula and aMDRD 
revealed a 30 % reduction in eGFR
10
. This study however did not use the gold 
standard method of measuring GFR, so its validity is questioned. 
PREGNANCY POST DONATION: 
Donors can contemplate pregnancy 6 months post donation, the time by which 
hypefiltration reaches maximum. There is no increased risk of complications in 
donors and age-matched cohorts. In an observation by Ramcharan and Matas
26
, 
33 donors reported 72 pregnancies, of which 25 had not been pregnant before 
donation. In this group of 33 donors, 2 had hypertension in the first trimester 
and 1 developed pre-eclampsia in third trimester. There was no increase in 
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proteinuria, deterioration in renal function or increase in maternal or fetal 
morbidity or mortality.  
 
LONG TERM MONITORING: 
The donors are advised to follow a healthy lifestyle, avoid smoking and 
tobacco, weight reduction and alcohol abstinence. They are advised to avoid 
Non- steroidal Anti-inflammatory drugs and other nephrotoxic drugs. In follow 
up visits, they should be evaluated for hypertension, proteinuria and current 
renal function. Donors with isolated medical abnormalities should be monitored 
at more frequent intervals. 
Overall, renal donors have an excellent quality of life, normal life span, no 
increased risk of ESRD and no increased risk of mortality with the age-matched 
general population
27
. 
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Subjects and Methods 
 
Study Design  : Cross sectional 
Study Place   : Kilpauk Medical College Hospital  
Study Population - Inclusion criteria: 
1. Kidney donors with minimum of 3 months post donation. 
2. And who have consented for the study. 
Exclusion criteria: 
1. Donors less than 3 months post donation 
2. Or those not willing to participate in the study 
Sample size  : 30 
Methodology : 
 The government hospitals in Tamilnadu have a policy to perform kidney 
transplant only between first degree relations, viz. parent, sibling, spouse or 
children. Because of this, most of their donors were readily available for 
evaluation.   
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40 transplant recipients are on foll0w-up in our hospital.30 donors met the 
inclusion criteria. 6 donors were not willing to participate in the study and 
excluded. One donor had died of uterine cancer 2 years post donation, but the 
recipient is still on regular follow-up. 3 donors could not be traced. 
The evaluation of donors was done in the out-patient setting. Their histories and 
previous medical records were reviewed. They underwent the following:  
1. Complete physical examination including blood pressure measurement. 
2. Urine analysis – routine, spot PCR (Protein Creatinine Ratio), 
3. Complete blood count/ peripheral smear study 
4. fasting blood sugar (FBS) 
5. serum creatinine and eGFR by CG formula, aMDRD and CKD EPI creatinie  
equations. 
6. ultrasound of abdomen 
7. 
99m
Tc - DTPA renogram 
All the results and observations were compared to their pre donation data and 
analyzed.  
Hypertension was diagnosed using JNC 7, Systolic BP > 140 mm of Hg and or 
Diastolic BP > 90 mm of Hg. 
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Complete blood count was done in all donors and peripheral smear study done 
if the Hb was less than 13.5 gm/ dl in males and less than 12 gm/dl in females. 
Microscopic hematuria is defined as the presence of > 5 RBCs /HPF. In case of 
microscopic hematuria, a sample was repeated after ruling out urinary tract 
infections, menses and other trivial causes. 
Normal spot PCR is < 0.3. spotPCR > 0.3 was considered significant and 
repeated to confirm abnormal spot PCR. 
Normal FBS is less than 100 mg/ dl. FBS more than 100 mg/ dl was repeated 
and classified as IFG, if it is between 100 to 125 mg dl and frank diabetes if 
greater than 125 mg/dl. 
Serum creatinine was measured by Modified Jaffes’ (Alkaline picrate) method. 
eGFR was calculated using Cockcroft - Gault formula, aMDRD and CKD EPI 
equations. Since most of the donors’ records did not have pre-donation 
creatinine clearances, it was not used for analysis in the study. 
USG of the abdomen focusing on the kidney size was done and compared to the 
pre-donation dimensions. The dimensions were also correlated with GFR 
measured by nuclear isotope scan, both pre and post donation. 
It is our unit protocol to do 
99m
Tc - DTPA renal isotope scan pre-donation, 
irrespective of the eGFR values. We subjected all the donors in the study to 
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isotope scan post donation. The pre-donation and post-donation 
99m
Tc - DTPA 
GFR was analyzed. Increase in remnant kidney GFR post donation; difference 
in GFR pre and post donation were analyzed. 
eGFR calculated by different equations were correlated with the GFR measured 
by isotope scan, both pre and post donation. This was done to assess the 
applicability of these equations in this population. 
CKD was diagnosed when GFR < 60 ml/ min. 
Conflict of interest: Nil 
Financial grants: Nil  
Statistical Analysis: was done using SPSS version 19.0 
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Results of the study 
 
Most  of the donors were more than eager to undergo a comprehensive 
evaluation. They readily consented for participating in the study after a detailed 
briefing.  
The earliest period of post – transplant evaluation was 4 months after transplant. 
The longest period was 156 months.  
Median period of follow-up was 29 months and is shown below. 
 
 
Of the 30 donors, 22 (73.3%) were females and 8 (26.7%) were males. 
Gender Number Percentage 
Male 8 26.7 
Female 22 73.3 
The age distribution of donors was as follows: 
0
1
2
3
4
5
6
7
8
9
≤ 1 year 1 - 2 yrs 2 - 3 yrs 3 - 4 yrs >4 yrs
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Age group (years) Number Percentage 
18 – 29 1 3.3 
30 – 39 7 23.3 
40 – 49 14 46.7 
> 50 8 26.7 
Total 30 100.0 
   
Majority (73.4%)  of the donors were in the fourth and fifth decade. 8 donors 
(26.7%) were above 50 years. The eldest donor was 58 years old at the time of 
donor nephrectomy and the youngest donor was a lady aged 24, who donated to 
her husband. 
5 donors (16%) had immediate post – operative complications. 2 had fever 
which subsided on the second day of surgery without any change in ongoing 
management. 2 donors developed pneumonia which required escalation of 
antibiotics. There was in delay in hospital stay. 1 donor developed wound 
dehiscence, requiring secondary suturing. No deaths occurred in the post-
surgical period. 
Blood pressure readings pre and post donation are as follows:  
Systolic BP Mean SEM Mean 
difference 
T value P value 
Pre 119.53 1.56 0.53 0.255 0.801 
Post 119.50 2.27 
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Diastolic BP Mean SEM Mean 
difference 
T value P value 
Pre 78.13 0.97 -0.67 -0.474 0.639 
Post 78.80 1.51 
 
Where,  
SEM refers to standard error of the mean. It denotes the number of samples if 
taken from the total will deviate from the mean. 
T value is the statistical value obtained by Paired t test. 
P value is to find out statistical significance, p < 0.05 is significant. 
The mean systolic BP pre-donation was 119.53 mm of Hg and post-donation 
was 119.50 mm of Hg and was not statistically different. The mean diastolic BP 
pre-donation was 78.13 mm of Hg and post-donation was 78.80 mm of Hg and 
was not statistically significant. Two of the 30 donors (6.7%) developed 
hypertension, as defined by JNC 7. 
Hemoglobin levels were as follows: 
Hb Mean SEM Mean 
difference 
T value P value 
Pre 11.40 0.18 0.27 1.035 0.309 
Post 11.13 0.29 
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The mean Hb pre-donation was 11.40% and it was 11.13% post-donation. The 
Hb values were not significant. 
spotPCR pre and post donation: 
Spcr Mean SEM Mean 
difference 
T value P value 
Pre 0.12 0.01 -0.05 -1.593 0.122 
Post 0.17 0.03 
 
There was a marginal rise in proteinuria from 0.12 to 0.17 post-donation, but it 
was not statistically significant. 
None of the donors developed microscopic hematuria post-donation. 
 
FBS pre and post donation are as follows: 
 
FBS Mean SEM Mean 
difference 
T value P value 
Pre 84.50 1.90 -7.40 -3.662 0.001 
Post 91.90 2.01 
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There was statistical difference with respect to FBS, pre and post donation. 5 of 
the donors developed IFG, but none of them developed frank diabetes. 
Serum creatinine, pre and post donation: 
 
Creatinine Mean SEM Mean 
difference 
T value P value 
Pre 0.84 0.02 -0.17 -6.638 0.001 
Post 1.01 0.03 
 
The mean serum creatinine was 0.84 pre-donation and was 1.01 post-donation 
and was statistically significant. 
Ultrasound of kidney, pre and post donation: 
Kidney dimensions, length and width, was measured in millimeters using 
ultrasound and kidney size or are was calculated and compared in pre and post 
donation. The depth could not be measured and hence, renal parenchymal 
volume could not be calculated. Ultrasound measurements were: 
Kidney 
length 
Mean SEM Mean 
difference 
T value P value 
Pre 98.77 1.26 -9.73 -6.282 0.001 
Post 108.50 1.67 
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Kidney 
width 
Mean SEM Mean 
difference 
T value P value 
Pre 41.17 0.99 -5.37 -5.388 0.001 
Post 46.53 1.23 
 
Kidney size Mean SEM Mean 
difference 
T value P value 
Pre 4082.80 135.29 -999.20 -6.041 0.001 
Post 5082.00 195.08 
 
The mean increase in length was 9.73mm and was statistically significant. The 
mean increase in breadth was 5.37 mm and was also significant. There was a 
mean 999.20 mm
2
 increase in surface area post donation and was statistically 
significant. 
eGFR pre and post donation: 
eGFR was calculated by CG formula, aMDRD and CKD EPI creatinine 
equation, pre and post donation. 
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eGFR by CG formula: 
eGFR by CG 
formula 
Mean SEM Mean 
difference 
T value P value 
Pre 97.93 2.47 15.46 6.494 0.001 
Post 72.47 2.67 
 
The mean eGFR calculated by CG formula was 97.93 ml/ min pre-donation and 
post donation it was 72.47 ml/ min, with a mean reduction by 15.46 ml/ min. 
eGFR by aMDRD equation: 
 
eGFR by 
aMDRD 
Mean SEM Mean 
difference 
T value P value 
Pre 84.34 3.46 17.37 5.807 0.001 
Post 66.97 2.59 
 
The mean eGFR calculated by aMDRD was 83.46 ml/ min pre-donation and 
post donation was 66.97 ml/ min with a mean reduction of 17.37 ml/ min. 
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eGFR by CKD EPI creatinine : 
eGFR by 
CKD EPI 
Mean SEM Mean 
difference 
T value P value 
Pre 93.17 3.17 18.00 6.999 0.001 
Post 75.17 2.93 
 
The mean eGFR calculated by CKD EPI cretinine equation was 93.17 ml/ min 
and 75.17 ml/ min, pre and post with a mean reduction of 18 ml/ min. There 
was correlation between the three equations with respect to reduction in GFR. 
GFR measured by 
99m
Tc DTPA pre and post: 
Total GFR 
by DTPA 
Mean SEM Mean 
difference 
T value P value 
Pre 102.53 1.70 21.76 11.715 0.001 
Post 80.77 1.14 
 
The mean GFR measured by 
99m
Tc DTPA pre and post donation were 102.53ml/ 
min and 80.77 ml/ min respectively, with a mean reduction in total GFR by 
21.76 ml/ min. 
Correlation of  eGFR vs GFR measured by 
99m
Tc DTPA 
Pearsons correlation was used to analyze the correlation between eGFR 
calculated by different equations and that measured by 
99m
Tc DTPA, in pre and 
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post donation.  They are shown by the images below, along with the correlation 
coefficient r and its p value. 
eGFR by CG vs total GFR by 
99m
Tc - DTPA (pre-donation): 
                           
Correlation coefficient r = 0.331, p = 0.074 
eGFR by CG vs 
99m
Tc - DTPA GFR (post donation): 
 
r = 0.071, p = 0.709 
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eGFR by aMDRD vs 
99m
Tc DTPA GFR (pre-donation): 
 
r = 0.291, p = 0.119 
eGFR by aMDRD vs 
99m
Tc DTPA GFR (post  donation): 
 
 
r = 0.164, p = 0.385 
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eGFR by CKD EPI vs 
99m
Tc - DTPA GFR(pre-donation): 
 
 
R = 0.340, p = 0.066 
eGFR by CKD EPI vs 
99m
Tc – DTPA GFR (post donation): 
 
 
r = 0.254, p = 0.175 
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Using Pearsons correlation coefficient, it was found that none of the equations 
for estimating GFR had significant correlation with GFR measured by
99mTc 
DTPA. This lack of correlation between eGFR and DTPA GFR led to 
misclassification of donors as CKD, even before transplantation! 
GFR < 60 ml/ min Pre-donation Post-donation 
CG FORMULA 1 4 
aMDRD 2 10 
CKD EPI creatinine 0 5 
99mTc DTPA 0 0 
 
Increase in measured GFR by 
99m
Tc DTPA in remnant kidney: 
 
DTPA total 
gain 
Mean SEM Mean 
difference 
T value P value 
Pre 50.87 1.11 -29.90 -22.182 0.001 
Post 80.77 1.14 
 
The mean GFR measured by 
99m
Tc DTPA of the remnant kidney, pre-donation 
was 50.87 ml/ min and post donation was 80.77 ml/ min. Hyperfiltration by the 
remnant kidney resulted in rise in GFR and it ranged from 16 ml/ min to 41 ml/ 
min and the mean rise in GFR was 29.90 ml/ min. 
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Age of the donor vs increase in DTPA GFR(post-donation): 
 
r = -0.362, p = 0.05 
There increase in GFR is more when the age of donor is less. In other words, 
older donors had less compensatory hyperfiltration.  This is the expected 
outcome and it was statistically significant. 
Increase in kidney size vs increase in DTPA GFR(post-donation): 
Kidney size had no correlation with DTPA GFR , both pre and post donation.  
Neither did the increase in kidney size and increase in GFR post donation. 
The graph depicting it lack of correlation is shown next. 
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R = 0.142, p = 0.455 
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Discussion  
Living donors form more than 95 percent of renal transplantations in India. 
They transform the lives of numerous ESRD patients by their generosity and 
selfless attitude. Most of them are related to their recipients. Being aware of the 
morbidity and mortality of CKD patients, most of the donors take good care of 
themselves to avoid the risk factors for development of CKD and ESRD. 
In our study of 30 donors, 22 were females (73.3%) and 8 were males (26.7%). 
There were 16 male recipients (53%) and 14 female recipients (47%). More 
females were donors and more recipients were males. This is similar to the 
observation in studies by Biller et al
28 
from Germany and Zimmermann et al
29
 
from Canada. It has been hypothesized that females think it is their duty to 
relieve the suffering of their spouse or children. Other factors include increased 
prevalence of hypertension in males, their higher earning capability and in 
spousal transplants, wives may be sensitized to their husbands during 
pregnancy. These make males less likely donors. 
In our study, of the 22 female donors, 13 donated to their children, 6 to their 
husbands and 3 to their brothers. Of the 8 male donors, 4 donated to their 
children, 2 to their wives and 2 to their siblings. 
In our center, open nephrectomy is done and the mean period of hospital stay is 
6 to 7 days. Of the 30 donors, 2 developed fever which subsided on the second 
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day, due to basal atelectasis(6%).2 donors developed pneumonia (6%)with need 
for escalation of antibiotics and its duration. Their hospital stay was not 
prolonged. One donor developed wound dehiscence (3%) which required 
secondary suturing and prolongation of hospital stay. Peri – operative 
complications are relatively common
30
 and include atelectasis (13.5% , 
prolonged ileus (5.2%), pneumonia (4.5%), urinary tract infection (4.3%). The 
surgical mortality in donor nephrectomy is reported to be 0.03%
23
.   
Though there was increase in spot protein creatinine ratio, from 0.13 to 0.17, it 
was not statistically significant. Though the incidence of late proteinuria in 
literature has been reported around 3%
30
, this has not been linked to the 
progression of renal disease.
 
None of the donors in our study had developed microscopic hematuria needing 
further evaluation. 
Though there was no statistical significance in Hemoglobin levels before and 
after renal donation. Six female donors had developed anemia post donation. 
They underwent peripheral smear study,  pelvic examination and occult blood in 
stool. Their peripheral smear study revealed microcytic hypochromic anemia. 
They improved with oral iron. 
The concerning issue was the development of impaired fasting glucose in 5 
donors (16.5%). One was a male donor and the rest were females. 4 of them 
56 
 
were overweight. The earliest period to development of IFG was 1 year post 
donation and latest was 6 years. No donor developed frank diabetes. These 
donors were advised lifestyle modifications, including weight reduction and to 
undergo frequent monitoring. In a long term study of living kidney donors, 19 
of 380(0.5%) developed diabetes over 6 to 34 years
31
.The incidence of diabetes 
has been similar to the general population. 
Two (6.6%) donors developed hypertension post donation. One was in JNC 
Stage 1and one was in JNC Stage 2. Both were obese, female donors more than 
50 years of age and 2 years post donation. The donor in JNC stage 1 was 
advised salt restriction, regular aerobic exercise, weight reduction and frequent 
monitoring. The other JNC Stage 2 hypertensive donor was started on single 
anti-hypertensive drug and given the same advice. The incidence of 
hypertension in donors has been reported to be the same as in general 
population. Some studies report increased risk of  hypertension in renal donors 
with increasing age and duration after donation
27
. 
 
The compensatory hyperfiltration by the remnant kidney leads to a maximum of 
70% of pre-donation GFR in about 6 months. There was a mean 29.90 ml/ min 
increase in the remnant kidney due to compensatory hyperfitration. The range of 
this increase was from 16 ml/ min to 41 ml/ min. The higher range of rise in 
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GFR was seen with younger donors. This is similar to the observation reported 
in literature
32
.   
The other side of it, kidney donation leads to loss of GFR by 30%. In our study, 
there was 0.17 increase in serum creatinine post donation which was statistically 
significant. The rise in creatinine resulted in statistically significant fall in 
estimated GFR calculated by the three equations, CG, aMDRD and CKD EPI 
creatinine, though all the three equations did not correlate with 
99m
Tc - DTPA 
GFR in this donor population. There was also statistically significant decline in 
99m
Tc - DTPA GFR, by an average of 21.76 ml/ min. This loss of GFR is similar 
to that reported in literature
33, 34
. 
The eGFR calculated by CG formula or the aMDRD and CKD EPI creatinine 
equations falsely classified many donors as CKD, one donor even prior to 
donation! This finding is an eye-opener to validate the eGFR equations in our 
population. 
In our donors, there remnant kidney increased its length, width and surface area, 
all of which were statistically significant. This compensatory increase in size 
did not correlate with the increase in remnant kidney 
99m
Tc -DTPA GFR. This is 
in contrast to the observation by Yasuhito Funahashi et al
31.  
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Conclusions: 
 
1. The GFR of remnant kidney of living kidney donors in our study is well 
within the normal range. 
2. The compensatory increase in remnant kidney GFR was more in younger 
donors. 
3. Impaired fasting glucose was seen in 16.5% of our donors and was of 
concern. 
4. Hypertension was seen in 6.5% of our donors, which is similar to that 
seen in general population. 
5. There was non-significant increase in proteinuria. 
6. Post-operative  complications were seen in 16.5% of our donors. 
7. There was significant increase in remnant kidney size.  
8. Estimation of GFR using CG formula, aMDRD and CKD EPI creatinine 
equations were not accurate in our donor population, when compared 
to
99m
Tc – DTPA GFR . Hence for accurate determination of GFR before 
donation in our donors, GFR measured by nuclear isotope methods 
should be used.  
9. With respect to the mean reduction in total GFR post donation, there was 
correlation between eGFR calculated by using CG formula, aMDRD and 
CKD EPI creatinine equations  
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Limitations of the study 
 
1. The number of donors in our study was small, only 30. 
2. The study was cross-sectional and the median period of follow-up was 
only 29 months. 
3. Creatinine clearance was not done in our donors and hence its 
significance and correlation with 
99m
TcDTPA GFR could not be assessed. 
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A CROSS SECTIONAL STUDY OF RENAL DONORS – PROFORMA 
Name   :      Age / Sex  :   
Date of Donor Nephrectomy  :  Side : Rt / Lt  Time since Tx :                 
Peri–operative complications ; 
Complaints ( if any ) : 
Examination : 
       Pre-transplant     Post-transplant 
BP   
Weight/ BMI   
Hb   
Urine Routine   
Urine spot PCR   
Fasting Blood sugar    
 Serum.Creatinine   
eGFR by CG formula   
eGFR by aMDRD equation   
eGFR by CKD-EPI 
creatinine  
  
USG KUB   
ECG   
99m
Tc – DTPA GFR   
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